Bridget Kearney is honoring her father’s legacy by running the 2018 Boston Marathon as part of Mass General’s Pediatric Cancer Marathon Team.
Treated at MassGeneral Hospital for Children for a rare brain tumor as a child, Callie McLaughlin, 24, is running the 2018 Boston Marathon as a member of Mass General’s Pediatric Cancer Team.
Excitement is growing for the promising potential of CAR-T cell immunotherapy, which was used to treat Harrison Morrow’s relapsing multiple myeloma.
A Mass General researcher who spent years studying how infectious diseases develop is using his expertise to develop a new approach to treating certain cancers.
Grateful for his cancer care he’s received at Mass General, Dan O’Connell is running the 2018 Boston Marathon as a member of Mass General’s Emergency Response Marathon Team.
A gastroenterologist finds that adding whole grains to the diet of colorectal cancer patients reduced their risk of death.
Mass General researchers are using liquid biopsies to detect early resistance to specific cancer treatments, knowledge that could help guide oncologists toward new courses of treatment.
Researchers at Mass General and MIT have harnessed the power of machine learning to develop a more accurate and less invasive screening method for high risk breast lesions.
Empowered by an effective targeted therapy provided by Massachusetts General Hospital, a man with advanced lung cancer heads high into the Himalayas.
Michael Blute, Sr., MD, chief of the Department of Urology, answers questions about prostate health and what men can do to protect themselves and their loved ones.